100 related articles for article (PubMed ID: 27509594)
1. Preclinical acute toxicity, biodistribution, pharmacokinetics, radiation dosimetry and microPET imaging studies of [(18)F]fluorocholine in mice.
Silveira MB; Ferreira SM; Nascimento LT; Costa FM; Mendes BM; Ferreira AV; Malamut C; Silva JB; Mamede M
Appl Radiat Isot; 2016 Oct; 116():92-101. PubMed ID: 27509594
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ
Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE
J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.
Bauman G; Belhocine T; Kovacs M; Ward A; Beheshti M; Rachinsky I
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):45-55. PubMed ID: 21844889
[TBL] [Abstract][Full Text] [Related]
6. Cancer imaging with fluorine-18-labeled choline derivatives.
Kwee SA; DeGrado TR; Talbot JN; Gutman F; Coel MN
Semin Nucl Med; 2007 Nov; 37(6):420-8. PubMed ID: 17920349
[TBL] [Abstract][Full Text] [Related]
7. Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients.
Fabbri C; Galassi R; Moretti A; Sintuzzi E; Mautone V; Sarti G; Strigari L; Benassi M; Matteucci F
Phys Med; 2014 May; 30(3):346-51. PubMed ID: 24238928
[TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of (111)In-BzDTPA-pertuzumab.
Lam K; Chan C; Done SJ; Levine MN; Reilly RM
Nucl Med Biol; 2015 Feb; 42(2):78-84. PubMed ID: 25459109
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
[TBL] [Abstract][Full Text] [Related]
11. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
12. PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer.
Zanzonico PB; Finn R; Pentlow KS; Erdi Y; Beattie B; Akhurst T; Squire O; Morris M; Scher H; McCarthy T; Welch M; Larson SM; Humm JL
J Nucl Med; 2004 Nov; 45(11):1966-71. PubMed ID: 15534070
[TBL] [Abstract][Full Text] [Related]
13. Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
Beauregard JM; Williams SG; Degrado TR; Roselt P; Hicks RJ
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):325-32. PubMed ID: 20718912
[TBL] [Abstract][Full Text] [Related]
14. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.
Beheshti M; Imamovic L; Broinger G; Vali R; Waldenberger P; Stoiber F; Nader M; Gruy B; Janetschek G; Langsteger W
Radiology; 2010 Mar; 254(3):925-33. PubMed ID: 20177103
[TBL] [Abstract][Full Text] [Related]
15. Imaging of Prostate Cancer Using
Hodolič M
PET Clin; 2017 Apr; 12(2):173-184. PubMed ID: 28267451
[No Abstract] [Full Text] [Related]
16. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
17. Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
Spaeth N; Wyss MT; Pahnke J; Biollaz G; Lutz A; Goepfert K; Westera G; Treyer V; Weber B; Buck A
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):673-82. PubMed ID: 16538503
[TBL] [Abstract][Full Text] [Related]
18. Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.
Bansal A; Shuyan W; Hara T; Harris RA; Degrado TR
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1192-203. PubMed ID: 18264706
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.
Kim YI; Cheon GJ; Paeng JC; Cho JY; Kwak C; Kang KW; Chung JK; Kim EE; Lee DS
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1247-56. PubMed ID: 25759164
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Oyama N; Ponde DE; Dence C; Kim J; Tai YC; Welch MJ
J Nucl Med; 2004 Mar; 45(3):519-25. PubMed ID: 15001697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
